Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Public companies: headquarters in San Diego County; ranked by fiscal 2006 revenues
- PUBLIC COMPANIES Headquarters in San Diego County; ranked by fiscal 2006 revenues ...
- Research articles 2007-12-31
- Public companies: headquarter in San Diego County; ranked by fiscal 2006 revenues
- PUBLIC COMPANIES Revenue ...
- Research articles 2007-09-17
- Biotech's New Blockbusters -- Oh, Really?
- Biotech's New Blockbusters -- Oh, Really?20 to 30 Blockbusters of Biotech Exist NowInnovation in Pharmacology?Beginning in the 1970, biopharmaceuticals were being researched for conceptual production in those places once called academic institutions. The first biopharmaceutical ever was a synthetic insulin called Humulin made by Genetech in 1982. Later...
- Discussion threads 2008-07-10
- Public companies: headquarters in San Diego County; ranked by fiscal 2005 revenues
- PUBLIC COMPANIES Headquarters in San Diego County, ranked by fiscal 2005 revenues ...
- Research articles 2006-12-25
- Corporate Profile for ThermoGenesis Corp., dated June 18, 1999
- --BUSINESS WIRE-- The following Corporate Profile is available for inclusion in your files. News releases for this client are distributed by Business Wire and also become part of the leading databases and online services, including all of the leading Internet-based services. -0- Published Date: June 18,...
- Research articles 1999-06-18
- Catalogue release. (Market focus: USA: an overview of the latest products and services from a selection of US companies).
- Millipore has released two catalogues featuring its tools, technologies and services. The 2002-2003 Biopharmaceutical catalogue highlights its filtration, purification and viral clearance selection tools and an expanded line of quality control ... Millipore has released two catalogues featuring its tools, technologies and services....
- Research articles 2002-09-01
Additional Resources
- IBC Life Sciences Announces Biopharmaceutical Development & Production Week March 2-6, 2009 in Carlsbad, California
- IBC is pleased to announce Biopharmaceutical Development & Production Week which includes five conferences focused on these specific biopharmaceutical disciplines: antibody development and production, outsourcing manufacturing, process validation, technology transfer and non-antibody protein therapeutics. This week long event provides biopharmaceutical professionals the opportunity to network face-to-face with 700 industry...
- Research articles 2008-12-11
- Advances in Large-Scale Biopharmaceutical Manufacturing: Introduction
- Biopharmaceutical manufacturers likely would agree that, beyond planning for safe, consistent products, expanding biotherapeutic product availability is a rational humanitarian and public sector goal. Reducing costs and complexities associated with production will increase availability to patients in both industrialized and developing nations for a larger number of diseases. Efficient production...
- White papers 2004-09-22
- Omnia Biologics and University of Maryland Bioprocess Scale-Up Facility Cooperate in Providing Biopharmaceutical Processing And Manufacture
- ROCKVILLE, Md. -- Biologics contract manufacturer Omnia Biologics, Inc. (Rockville, MD) and University of Maryland Bioprocess Scale-Up Facility BSF (College Park, MD) today announced an agreement to cooperate in providing services for the manufacture of biopharmaceutical products. Omnia Biologics Omnia is a contract manufacturer focused on the development of innovative...
- Research articles 2005-05-12
- Shortening biopharmaceutical approval times.(Biotechnology 97)
- Biopharmaceutical companies join the push to accelerate FDA's drug review and approval times and look to FDA involvement earlier in drug development. Biopharmaceutical companies join the push to accelerate FDA's drug review and approval times and look to FDA involvement earlier in...
- Research articles 1997-04-14
- Elan elaborates on recovery plan. (Breaking News Roundup).(Biopharmaceutical company to focus on neurology, pain and autoimmune diseases)(International Pages)(Brief Article)(Statistical Data Included)
- Elan Corp. unveiled a recovery plan to restructure itself into a new biopharmaceutical company focused on neurology, pain and autoimmune diseases. Key to the plan was Elan's purchase, for a net $82.5 million, of royalty rights held by Autoimmune Di Elan Corp. unveiled a...
- Research articles 2002-08-05
- Biopharmaceutical Industry has Bright Future, Industry Leaders Assert; Mayfield Fund and Wilson Sonsini Goodrich & Rosati Annual Conference Explores Issues Facing Industry Today
- REDWOOD SHORES, Calif.--BUSINESS WIRE--Feb. 8, 1999--While acknowledging that this is a difficult time for the biopharmaceutical sector, industry executives attending a conference on the state of the biopharmaceutical industry agreed that the long-term prospects for the industry remain strong.
- Research articles 1999-02-08
- Government Forced to Disclose Locations of Test Sites of Biopharmaceutical Crops
- HONOLULU, Feb. 8 /U.S. Newswire/ -- In a first step toward public disclosure of test sites of biopharmaceutical crops, the U.S. Department of Agriculture was forced by court order on February 4 to reveal the locations of these sites in Hawai`i. Following HONOLULU, Feb. 8 /U.S. Newswire/ -- In a...
- Research articles 2005-02-08
- Dow BCMS to Build R&D, Development.(Dow Biopharmaceutical Contract Manufacturing Services)(Brief Article)(Statistical Data Included)
- DOW BIOPHARMACEUTICAL Contract Manufacturing Services received zoning approval last Wednesday for the construction of a 43,000-square-foot laboratory and process development facility. To be located at BCMS's Smithfield, R.I., site, it will be the f DOW BIOPHARMACEUTICAL Contract Manufacturing Services received zoning approval last...
- Research articles 2001-07-02
- Elan Corporation plc, the Irish-based biopharmaceutical company.(revenue information)(Brief Article)(Statistical Data Included)
- * Elan Corporation plc, the Irish-based biopharmaceutical company, has reported that its total ... * Elan Corporation plc, the Irish-based biopharmaceutical company, has reported that its total revenue for the first quarter of 2002 was $443.6mn, compared with $429.3mn for the same period of 2001.
- Research articles 2002-05-25
- Pall Launches New Fluid Management Technologies for the Biopharmaceutical Industry at INTERPHEX2007
- EAST HILLS, N.Y. -- The increasing focus on biotechnology and personalized medicines along with the growth of the vaccine marketplace is changing the face of the biopharmaceutical industry, an $80 billion global market. Drug manufacturers are challenged by cost pressures, the need for shorter production times and rapid scale-up, as...
- Research articles 2007-04-25
- Biopharmaceutical Firm Heals Itself From Short List.
- M2 PRESSWIRE-30 September 2005-Emerging Stock Report: Biopharmaceutical Firm Heals Itself From Short ListC1994-2005 M2 COMMUNICATIONS LTD RDATE:30092005 The Emerging Stock Report is following NOVAVAX (NASDAQ: NVAX), a specialty biopharmaceutical company, that engages in the research, development, and commercialization of products...
- Research articles 2005-09-30
- Gain an Insight into the View of the US Biopharmaceutical Industry on Cross-border Alliances.
- M2 PRESSWIRE-29 August 2006-Research and Markets: Gain an Insight into the View of the US Biopharmaceutical Industry on Cross-border AlliancesC1994-2006 M2 COMMUNICATIONS LTD RDATE:29082006 Dublin: Research and Markets (http://www.researchandmarkets.com/reports/c41350) has announced the addition of Cross Broder Alliances in Biopharma Industry...
- Research articles 2006-08-29
- TIANJIN BUILDS NATIONAL BIOPHARMACEUTICAL CAMPUS
- AsiaInfo Services 06-28-2007 Tianjin Builds National Biopharmaceutical Campus TIANJIN, Jun 28, 2007 SinoCast via COMTEX -- A national-level biopharmaceutical innovation park will be built in northern China's coastal city of Tianjin, as the agreement signed between the municipal government and the...
- Research articles 2007-06-28
- Biopharmaceutical Industry Leaders to Discuss Financing Strategies; WSGR and Mayfield Fund Annual Conference Promises Unique Insights
- PALO ALTO, Calif.--BW HealthWire--Jan. 26, 1999-- Biopharmaceutical industry leaders will convene on February 4 at a conference to discuss strategies for financing their companies in 1999. The conference, "Financing the Biopharmaceutical Company," is sponsored by Wilson Sonsini Goodrich & Rosati WSGR and Mayfield Fund. Edward E. Penhoet, Ph.D., director...
- Research articles 1999-01-26
- << Previous
- page 1 of 1
- Next >>
